PF-08049820: Clinical Trials

1 trial of PF-08049820, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow PF-08049820: new trials by email Literature Review of PF-08049820 trials Research Report on PF-08049820

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
PF-08049820, Placebo - Atopic Dermatitis, Eczema, Atopic
Phase 2RecruitingPfizer1652025-11-202026-11-05

Conditions studied

Dermatitis, Atopic (1)  ·  Eczema (1)

Sponsors

Pfizer (1)

Countries

Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Japan (1)  ·  Poland (1)  ·  United States (1)

NIH funding

2025 (1)